The molecule itself is a modified form of insulin-like growth factor 1 carrying two deliberate changes that reduce its capture by the IGF binding proteins, which is why it is used as a cell-culture supplement
Their growing impact is evidenced by regulatory approvals and market performance
The somatomedin hypothesis which was first proposed in the early 1970s, provided a model for IGF1 actions on the skeleton (see Figure 2 ) elaborated in igf-1 global knockouts, as will be discussed in more detail in a later section, show infertility and profound growth retardation at birth, phenotypes that are not observed in GH- or GH receptor-null animals
It is also used for fibromyalgia, rosacea, and other illnesses, although there is little evidence supporting these claims
Persistent or worsening fatigue beyond several months warrants medical review to exclude anaemia, thyroid dysfunction, or other contributing conditions